APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Pharmaceuticals and Supplements

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Selected research

Market Structure

Global Equine Pharmaceuticals and Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025192 pages

Choose your research edition.

Industry ResearchEquine Pharmaceuticals and Supplements Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Pharmaceuticals and Supplements Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Equine Pharmaceuticals and Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Pharmaceuticals and Supplements Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Pharmaceuticals and Supplements Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.

North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.

Read the full market overview

In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.

This report provides an overview of the global Equine Pharmaceuticals and Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Equine Pharmaceuticals and Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Equine Pharmaceuticals and Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Equine Pharmaceuticals and Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.

Equine Pharmaceuticals and Supplements Segment by Company

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Equine Pharmaceuticals and Supplements Segment by Type

Pharmaceuticals

Supplements

Equine Pharmaceuticals and Supplements Segment by Application

Thoroughbred Horse

Other Types of Horses

Equine Pharmaceuticals and Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Pharmaceuticals and Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Equine Pharmaceuticals and Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Equine Pharmaceuticals and Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Equine Pharmaceuticals and Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Equine Pharmaceuticals and Supplements Industry Trends Table 2. Equine Pharmaceuticals and Supplements Industry Drivers Table 3. Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges Table 4. Equine Pharmaceuticals and Supplements Industry Restraints Table 5. Global Equine Pharmaceuticals and Supplements Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers Table 9. Global Equine Pharmaceuticals and Supplements Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Equine Pharmaceuticals and Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Equine Pharmaceuticals and Supplements Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Equine Pharmaceuticals and Supplements Manufacturers, Product Type & Application Table 13. Global Equine Pharmaceuticals and Supplements Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Equine Pharmaceuticals and Supplements by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pharmaceuticals Table 17. Major Manufacturers of Supplements Table 18. Global Equine Pharmaceuticals and Supplements Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 20. Global Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 21. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2026) Table 22. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2027-2032) Table 23. Global Equine Pharmaceuticals and Supplements Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (K Units) Table 25. Global Equine Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (K Units) Table 26. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2026) Table 27. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Thoroughbred Horse Table 29. Major Manufacturers of Other Types of Horses Table 30. Global Equine Pharmaceuticals and Supplements Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 32. Global Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 33. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2026) Table 34. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2027-2032) Table 35. Global Equine Pharmaceuticals and Supplements Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (K Units) Table 37. Global Equine Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (K Units) Table 38. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2026) Table 39. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2027-2032) Table 40. Global Equine Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units) Table 42. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2021-2026) Table 43. Global Equine Pharmaceuticals and Supplements Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Equine Pharmaceuticals and Supplements Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Equine Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 47. North America Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 48. Europe Equine Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 50. Europe Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Equine Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Equine Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 57. Global Equine Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Equine Pharmaceuticals and Supplements Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2026) Table 61. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2027-2032) Table 62. Boehringer Ingelheim Company Information Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio Table 66. Boehringer Ingelheim Recent Development Table 67. Merck Animal Health Company Information Table 68. Merck Animal Health Business Overview Table 69. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 71. Merck Animal Health Recent Development Table 72. Zoetis Company Information Table 73. Zoetis Business Overview Table 74. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Zoetis Equine Pharmaceuticals and Supplements Product Portfolio Table 76. Zoetis Recent Development Table 77. Bayer Animal Health Company Information Table 78. Bayer Animal Health Business Overview Table 79. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 81. Bayer Animal Health Recent Development Table 82. Elanco Animal Health Company Information Table 83. Elanco Animal Health Business Overview Table 84. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 86. Elanco Animal Health Recent Development Table 87. Dechra Veterinary Products Company Information Table 88. Dechra Veterinary Products Business Overview Table 89. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio Table 91. Dechra Veterinary Products Recent Development Table 92. CEVA Company Information Table 93. CEVA Business Overview Table 94. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. CEVA Equine Pharmaceuticals and Supplements Product Portfolio Table 96. CEVA Recent Development Table 97. Virbac Company Information Table 98. Virbac Business Overview Table 99. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Virbac Equine Pharmaceuticals and Supplements Product Portfolio Table 101. Virbac Recent Development Table 102. Norbrook Equine Company Information Table 103. Norbrook Equine Business Overview Table 104. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio Table 106. Norbrook Equine Recent Development Table 107. Kyoritsu Seiyaku Company Information Table 108. Kyoritsu Seiyaku Business Overview Table 109. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio Table 111. Kyoritsu Seiyaku Recent Development Table 112. Vetoquinol Company Information Table 113. Vetoquinol Business Overview Table 114. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio Table 116. Vetoquinol Recent Development Table 117. Protexin Healthcare Company Information Table 118. Protexin Healthcare Business Overview Table 119. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio Table 121. Protexin Healthcare Recent Development Table 122. Audevard Company Information Table 123. Audevard Business Overview Table 124. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Audevard Equine Pharmaceuticals and Supplements Product Portfolio Table 126. Audevard Recent Development Table 127. Ouro Fino Saude Company Information Table 128. Ouro Fino Saude Business Overview Table 129. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio Table 131. Ouro Fino Saude Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Equine Pharmaceuticals and Supplements Distributors List Table 135. Equine Pharmaceuticals and Supplements Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Equine Pharmaceuticals and Supplements Product Image Figure 2. Global Equine Pharmaceuticals and Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Pharmaceuticals and Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Equine Pharmaceuticals and Supplements Sales (2021-2032) & (K Units) Figure 5. Global Equine Pharmaceuticals and Supplements Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Equine Pharmaceuticals and Supplements Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pharmaceuticals Image Figure 9. Supplements Image Figure 10. Global Equine Pharmaceuticals and Supplements Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Equine Pharmaceuticals and Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032) Figure 13. Global Equine Pharmaceuticals and Supplements Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032) Figure 16. Thoroughbred Horse Image Figure 17. Other Types of Horses Image Figure 18. Global Equine Pharmaceuticals and Supplements Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Equine Pharmaceuticals and Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032) Figure 21. Global Equine Pharmaceuticals and Supplements Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Equine Pharmaceuticals and Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032) Figure 24. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 26. U.S. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 31. Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 38. China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 46. Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Equine Pharmaceuticals and Supplements Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 57. North America Equine Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 59. Europe Equine Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Equine Pharmaceuticals and Supplements Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Equine Pharmaceuticals and Supplements Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceuticals
  • Supplements
Applications
  • Thoroughbred Horse
  • Other Types of Horses
Companies covered
  • Boehringer Ingelheim
  • Merck Animal Health
  • Zoetis
  • Bayer Animal Health
  • Elanco Animal Health
  • Dechra Veterinary Products
  • CEVA
  • Virbac
  • Norbrook Equine
  • Kyoritsu Seiyaku
  • Vetoquinol
  • Protexin Healthcare
  • Audevard
  • Ouro Fino Saude

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Equine Pharmaceuticals and Supplements Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Equine Pharmaceuticals and Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Equine Pharmaceuticals and Supplements Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Equine Pharmaceuticals and Supplements Market Dynamics
  1. 2.1 Equine Pharmaceuticals and Supplements Industry Trends
  2. 2.2 Equine Pharmaceuticals and Supplements Industry Drivers
  3. 2.3 Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges
  4. 2.4 Equine Pharmaceuticals and Supplements Industry Restraints
3 Equine Pharmaceuticals and Supplements Market by Manufacturers
  1. 3.1 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2021-2026)
  3. 3.3 Global Equine Pharmaceuticals and Supplements Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Equine Pharmaceuticals and Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Equine Pharmaceuticals and Supplements Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Equine Pharmaceuticals and Supplements Manufacturers, Product Type & Application
  7. 3.7 Global Equine Pharmaceuticals and Supplements Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Equine Pharmaceuticals and Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Equine Pharmaceuticals and Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Equine Pharmaceuticals and Supplements Tier 1, Tier 2, and Tier 3
4 Equine Pharmaceuticals and Supplements Market by Type
  1. 4.1 Equine Pharmaceuticals and Supplements Type Introduction
  2. 4.1.1 Pharmaceuticals
  3. 4.1.2 Supplements
  4. 4.2 Global Equine Pharmaceuticals and Supplements Sales by Type
  5. 4.2.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2032)
  7. 4.2.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032)
  8. 4.3 Global Equine Pharmaceuticals and Supplements Revenue by Type
  9. 4.3.1 Global Equine Pharmaceuticals and Supplements Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2021-2032)
  11. 4.3.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032)
5 Equine Pharmaceuticals and Supplements Market by Application
  1. 5.1 Equine Pharmaceuticals and Supplements Application Introduction
  2. 5.1.1 Thoroughbred Horse
  3. 5.1.2 Other Types of Horses
  4. 5.2 Global Equine Pharmaceuticals and Supplements Sales by Application
  5. 5.2.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2032)
  7. 5.2.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032)
  8. 5.3 Global Equine Pharmaceuticals and Supplements Revenue by Application
  9. 5.3.1 Global Equine Pharmaceuticals and Supplements Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2021-2032)
  11. 5.3.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032)
6 Global Equine Pharmaceuticals and Supplements Sales by Region
  1. 6.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2032)
  3. 6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026)
  4. 6.2.2 Global Equine Pharmaceuticals and Supplements Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Equine Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Equine Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Equine Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Equine Pharmaceuticals and Supplements Revenue by Region
  1. 7.1 Global Equine Pharmaceuticals and Supplements Revenue by Region
  2. 7.1.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026)
  4. 7.1.3 Global Equine Pharmaceuticals and Supplements Revenue by Region (2027-2032)
  5. 7.1.4 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Equine Pharmaceuticals and Supplements Revenue (2021-2032)
  8. 7.2.2 North America Equine Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Equine Pharmaceuticals and Supplements Revenue (2021-2032)
  11. 7.3.2 Europe Equine Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Equine Pharmaceuticals and Supplements Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Merck Animal Health
  8. 8.2.1 Merck Animal Health Company Information
  9. 8.2.2 Merck Animal Health Business Overview
  10. 8.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  12. 8.2.5 Merck Animal Health Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Bayer Animal Health
  20. 8.4.1 Bayer Animal Health Company Information
  21. 8.4.2 Bayer Animal Health Business Overview
  22. 8.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  24. 8.4.5 Bayer Animal Health Recent Developments
  25. 8.5 Elanco Animal Health
  26. 8.5.1 Elanco Animal Health Company Information
  27. 8.5.2 Elanco Animal Health Business Overview
  28. 8.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  30. 8.5.5 Elanco Animal Health Recent Developments
  31. 8.6 Dechra Veterinary Products
  32. 8.6.1 Dechra Veterinary Products Company Information
  33. 8.6.2 Dechra Veterinary Products Business Overview
  34. 8.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
  36. 8.6.5 Dechra Veterinary Products Recent Developments
  37. 8.7 CEVA
  38. 8.7.1 CEVA Company Information
  39. 8.7.2 CEVA Business Overview
  40. 8.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
  42. 8.7.5 CEVA Recent Developments
  43. 8.8 Virbac
  44. 8.8.1 Virbac Company Information
  45. 8.8.2 Virbac Business Overview
  46. 8.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
  48. 8.8.5 Virbac Recent Developments
  49. 8.9 Norbrook Equine
  50. 8.9.1 Norbrook Equine Company Information
  51. 8.9.2 Norbrook Equine Business Overview
  52. 8.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
  54. 8.9.5 Norbrook Equine Recent Developments
  55. 8.10 Kyoritsu Seiyaku
  56. 8.10.1 Kyoritsu Seiyaku Company Information
  57. 8.10.2 Kyoritsu Seiyaku Business Overview
  58. 8.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
  60. 8.10.5 Kyoritsu Seiyaku Recent Developments
  61. 8.11 Vetoquinol
  62. 8.11.1 Vetoquinol Company Information
  63. 8.11.2 Vetoquinol Business Overview
  64. 8.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
  66. 8.11.5 Vetoquinol Recent Developments
  67. 8.12 Protexin Healthcare
  68. 8.12.1 Protexin Healthcare Company Information
  69. 8.12.2 Protexin Healthcare Business Overview
  70. 8.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
  72. 8.12.5 Protexin Healthcare Recent Developments
  73. 8.13 Audevard
  74. 8.13.1 Audevard Company Information
  75. 8.13.2 Audevard Business Overview
  76. 8.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
  78. 8.13.5 Audevard Recent Developments
  79. 8.14 Ouro Fino Saude
  80. 8.14.1 Ouro Fino Saude Company Information
  81. 8.14.2 Ouro Fino Saude Business Overview
  82. 8.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
  84. 8.14.5 Ouro Fino Saude Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
  2. 9.1.1 Equine Pharmaceuticals and Supplements Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Equine Pharmaceuticals and Supplements Production Mode & Process
  6. 9.2 Equine Pharmaceuticals and Supplements Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Equine Pharmaceuticals and Supplements Distributors
  9. 9.2.3 Equine Pharmaceuticals and Supplements Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst